Key Lessons & Opportunities in applying NCA and PopPK to ADCs
Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…
Certara2025 年 10 月 24 日
Certara Scientists are Among the Topmost Cited Biopharma Researchers
Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…
Certara2025 年 10 月 20 日
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results
Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…
Danielle Pillsbury2025 年 10 月 15 日
MBMA vs. Meta-Analysis: Quick Comparison Guide
Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…
Certara2025 年 10 月 8 日
U.S. International Reference Pricing: Global Implications and Pharma Strategy
Unintended global fallout of international reference pricing: How the U.S. Most Favored Nation policy could…
Certara2025 年 10 月 6 日
Highlights from the FDA Guidance on Dosage Optimization for Therapeutic Radiopharmaceuticals
Learn how radiopharmaceutical therapies work in oncology and how Certara supports development with modeling, simulation,…
Certara2025 年 10 月 3 日
